BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 12079221)

  • 21. Immunosuppression and squamous cell carcinoma: a focus on solid organ transplant recipients.
    Herman S; Rogers HD; Ratner D
    Skinmed; 2007; 6(5):234-8. PubMed ID: 17786101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignancy after Solid Organ Transplantation: Comprehensive Imaging Review.
    Katabathina VS; Menias CO; Tammisetti VS; Lubner MG; Kielar A; Shaaban A; Mansour J; Surabhi VR; Hara AK
    Radiographics; 2016; 36(5):1390-407. PubMed ID: 27618321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous manifestations of immunosuppression in organ transplant recipients.
    Abel EA
    J Am Acad Dermatol; 1989 Aug; 21(2 Pt 1):167-79. PubMed ID: 2671063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-melanoma skin cancer is reduced after switch of immunosuppression to mTOR-inhibitors in organ transplant recipients.
    Alter M; Satzger I; Schrem H; Kaltenborn A; Kapp A; Gutzmer R
    J Dtsch Dermatol Ges; 2014 Jun; 12(6):480-8. PubMed ID: 24813579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sun exposure behavior and protection: recommendations for travelers.
    Diaz JH; Nesbitt LT
    J Travel Med; 2013; 20(2):108-18. PubMed ID: 23464719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skin cancer in organ transplant recipients.
    Kempf W; Mertz KD; Hofbauer GF; Tinguely M
    Pathobiology; 2013; 80(6):302-9. PubMed ID: 24013135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-renal transplant malignancies: Opportunities for prevention and early screening.
    Turshudzhyan A
    Cancer Treat Res Commun; 2021; 26():100283. PubMed ID: 33338850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skin cancer in liver transplant recipients.
    Otley CC; Pittelkow MR
    Liver Transpl; 2000 May; 6(3):253-62. PubMed ID: 10827224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic strategies for chemoprevention of skin cancers in transplant recipients.
    Kovach BT; Sams HH; Stasko T
    Clin Transplant; 2005 Dec; 19(6):726-34. PubMed ID: 16313317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre- and posttransplant management of solid organ transplant recipients: risk-adjusted follow-up.
    Shafaeddin Schreve B; Anliker M; Arnold AW; Kempf W; Laffitte E; Lapointe AK; Mainetti C; Pelloni F; Oberholzer P; Serra A; Streit M; Hofbauer GF;
    Curr Probl Dermatol; 2012; 43():57-70. PubMed ID: 22377920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of Skin Cancer and Related Skin Tumors in High-Risk Kidney and Liver Transplant Recipients in Queensland, Australia.
    Iannacone MR; Sinnya S; Pandeya N; Isbel N; Campbell S; Fawcett J; Soyer PH; Ferguson L; Davis M; Whiteman DC; Green AC;
    J Invest Dermatol; 2016 Jul; 136(7):1382-1386. PubMed ID: 26968258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin lesions in organ transplant recipients: a study of 177 consecutive Brazilian patients.
    Oliveira WRP; Tirico MCCP; Souza AAV; Codarin FR; Silva LLC; Festa Neto C
    Int J Dermatol; 2019 Apr; 58(4):440-448. PubMed ID: 30565651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Keratinocyte cancer and its precursors in organ transplant patients.
    Jenni D; Hofbauer GF
    Curr Probl Dermatol; 2015; 46():49-57. PubMed ID: 25561206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reducing skin malignancy risk in organ transplant recipients.
    Francis S; Berg D
    Skin Therapy Lett; 2013 Jan; 18(1):1-3. PubMed ID: 23474655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials.
    Chen K; Craig JC; Shumack S
    Br J Dermatol; 2005 Mar; 152(3):518-23. PubMed ID: 15787821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of Topical and Systemic Retinoids in Solid Organ Transplant Recipients: Update and Review of the Current Literature.
    Herold M; Good AJ; Nielson CB; Longo MI
    Dermatol Surg; 2019 Dec; 45(12):1442-1449. PubMed ID: 31403546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinoids for the management of dermatological complications of organ transplantation.
    Euvrard S; Kanitakis J; Thivolet J; Claudy A
    BioDrugs; 1997 Sep; 8(3):176-84. PubMed ID: 18020508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skin cancers in organ transplant recipients.
    Euvrard S; Kanitakis J; Pouteil-Noble C; Claudy A; Touraine JL
    Ann Transplant; 1997; 2(4):28-32. PubMed ID: 9869876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. De Novo Skin Neoplasms in Liver-Transplanted Patients: Single-Center Prospective Evaluation of 105 Cases.
    Paganelli A; Magistri P; Kaleci S; Chester J; Pezzini C; Catellani B; Ciardo S; Casari A; Giusti F; Bassoli S; Di Sandro S; Pellacani G; Farnetani F; Di Benedetto F
    Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295604
    [No Abstract]   [Full Text] [Related]  

  • 40. Langerhans cells in benign, premalignant and malignant skin lesions of renal transplant recipients and the effect of retinoid therapy.
    Gibson GE; O'Grady A; Kay EW; Leader M; Murphy GM
    J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):130-6. PubMed ID: 9553909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.